Table 1.

Multilineage Stem Cell Activity and High CRU Levels Are Maintained in AFT024 Cultures

CellsWeekLineage Contribution, % Ly5.2 CellsTotal % Ly5.2CRU/105
CD4CD8B220Myeloid
With 1,000 purified fetal liver cells* 
Control 3.3 ± 1.5 4.4 ± 1.7 48 ± 5.1 32 ± 6.0 28 ± 1.3 386 ± 24 
 12 27 ± 10 24 ± 8.7 63 ± 8.9 43 ± 9.2 44 ± 3.2 800 ± 102 
 24 42 ± 6.9 34 ± 4.1 71 ± 4.4 62 ± 1.4 48 ± 4.8 984 ± 171 
AFT024 7.7 ± 6.2 6.0 ± 3.5 58 ± 6.6 36 ± 4.7 39 ± 2.1 641 ± 54 
 12 44 ± 7.1 38 ± 6.4 70 ± 5.6 53 ± 3.6 48 ± 1.4 942 ± 51 
 24 56 ± 3.8 49 ± 3.1 72 ± 2.4 64 ± 3.7 56 ± 1.9 1,270 ± 96 
2012 0.8 ± 0.5 1.4 ± 0.3 6.8 ± 3.6 14 ± 11 7.4 ± 2.3 52 ± 8.5 
 12 9.1 ± 8.4 10 ± 6.9 14 ± 9.3 23 ± 20 14 ± 4.5 194 ± 68 
 24 17 ± 3.8 18 ± 2.0 23 ± 5.9 32 ± 6.4 21 ± 4.4 196 ± 71 
        
Cells Week Lineage Contribution, % Ly5.2 Cells CRU/105 
  Myeloid B Cells T Cells Total %  
      Ly 5.2  
CellsWeekLineage Contribution, % Ly5.2 CellsTotal % Ly5.2CRU/105
CD4CD8B220Myeloid
With 1,000 purified fetal liver cells* 
Control 3.3 ± 1.5 4.4 ± 1.7 48 ± 5.1 32 ± 6.0 28 ± 1.3 386 ± 24 
 12 27 ± 10 24 ± 8.7 63 ± 8.9 43 ± 9.2 44 ± 3.2 800 ± 102 
 24 42 ± 6.9 34 ± 4.1 71 ± 4.4 62 ± 1.4 48 ± 4.8 984 ± 171 
AFT024 7.7 ± 6.2 6.0 ± 3.5 58 ± 6.6 36 ± 4.7 39 ± 2.1 641 ± 54 
 12 44 ± 7.1 38 ± 6.4 70 ± 5.6 53 ± 3.6 48 ± 1.4 942 ± 51 
 24 56 ± 3.8 49 ± 3.1 72 ± 2.4 64 ± 3.7 56 ± 1.9 1,270 ± 96 
2012 0.8 ± 0.5 1.4 ± 0.3 6.8 ± 3.6 14 ± 11 7.4 ± 2.3 52 ± 8.5 
 12 9.1 ± 8.4 10 ± 6.9 14 ± 9.3 23 ± 20 14 ± 4.5 194 ± 68 
 24 17 ± 3.8 18 ± 2.0 23 ± 5.9 32 ± 6.4 21 ± 4.4 196 ± 71 
        
Cells Week Lineage Contribution, % Ly5.2 Cells CRU/105 
  Myeloid B Cells T Cells Total %  
      Ly 5.2  
With 100 purified fetal liver cells 
AFT024 15 33 ± 4.6 41 ± 6.0 25 ± 5.3 28 ± 4.6 1,888 ± 315 
        
 26 17 ± 4.4 18 ± 4.8 18 ± 5.9 24 ± 5.9 1,825 ± 571 
        
 46 22 ± 5.7 19 ± 6.6 15 ± 6.7 20 ± 6.5 1,595 ± 628 
        
2012 15 32 ± 7.8 28 ± 7.2 20 ± 5.2 24 ± 6.6 1,390 ± 382 
        
 26 10 ± 2.8 9.7 ± 3.2 9.7 ± 3.2 14 ± 3.9 699 ± 176 
        
 46 11 ± 2.3 6.7 ± 1.6 8.9 ± 3.2 9.0 ± 2.0 409 ± 80 
        
Cells  Lineage Contribution, % Ly5.1 Cells Total % CRU/105 
  CD4 CD8 B220 Myeloid Ly5.1  
With 100 purified fetal liver cells 
AFT024 15 33 ± 4.6 41 ± 6.0 25 ± 5.3 28 ± 4.6 1,888 ± 315 
        
 26 17 ± 4.4 18 ± 4.8 18 ± 5.9 24 ± 5.9 1,825 ± 571 
        
 46 22 ± 5.7 19 ± 6.6 15 ± 6.7 20 ± 6.5 1,595 ± 628 
        
2012 15 32 ± 7.8 28 ± 7.2 20 ± 5.2 24 ± 6.6 1,390 ± 382 
        
 26 10 ± 2.8 9.7 ± 3.2 9.7 ± 3.2 14 ± 3.9 699 ± 176 
        
 46 11 ± 2.3 6.7 ± 1.6 8.9 ± 3.2 9.0 ± 2.0 409 ± 80 
        
Cells  Lineage Contribution, % Ly5.1 Cells Total % CRU/105 
  CD4 CD8 B220 Myeloid Ly5.1  
With 100 purified BM cells 
Control (n = 8)  38 ± 7.3 30 ± 5.8 43 ± 6.7 31 ± 4.8 32 ± 6.5 583 ± 172 
AFT024 (n = 7)  20 ± 9.8 18 ± 8.8 20 ± 8.7 24 ± 11 22 ± 10 490 ± 296 
With 100 purified BM cells 
Control (n = 8)  38 ± 7.3 30 ± 5.8 43 ± 6.7 31 ± 4.8 32 ± 6.5 583 ± 172 
AFT024 (n = 7)  20 ± 9.8 18 ± 8.8 20 ± 8.7 24 ± 11 22 ± 10 490 ± 296 
*

AA4.1+ day 14 fetal liver cells (Ly5.2) were further purified for a lin−/lo, Sca-1+, c-kit+ stem cell surface phenotype. Fresh purified control cells (103) were transplanted with 106 Ly5.1 competitor marrow (n = 6 mice). From the same purification, 104 cells were cocultured with stromal cell lines for 4 weeks. Subsequently, 10% of each culture was transplanted per mouse (n = 8 mice/stroma) together with 106 competitor BM cells. The contribution to each lineage in peripheral blood is expressed as the percent of the total specific lineage population that was Ly5.2+. CRU/105, relative enrichment of competitive repopulating units. Data are the mean ± SEM.

The lineage and CRU content of low numbers of enriched fetal liver stem cells maintained on AFT024 and 2012 were determined. 500 stem cells were maintained in Dexter LTC for 4 to 7 weeks over irradiated monolayers. 20% of each culture was used to transplant groups of 4 mice (ie, each mouse received the equivalent of 100 stem cells that initially seeded the cultures) combined with 4 × 105 competitor BM cells. Data are the mean ± SEM.

Ly5.1 BM cells with a lin−/lo, Sca-1+, and c-kit+ cell surface phenotype were purified. 100 fresh cells per mouse (control) were transplanted with 105 Ly5.2 competitor BM cells. One thousand of the same purified cells were cocultured with stromal cell lines for 6 weeks. The cultures were then harvested, and 10% of each culture was transplanted per mouse with competitor. Data are from peripheral blood samples taken 4 months after transplant and are the mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal